Clinical trials
Research Shows that the Pfizer Vaccine can only Partially Protect against Omicron
The coronavirus variant Omicron may partially evade protection from two doses of vaccine produced by Pfizer Inc. and partner BioNTech, Alex Seagal, head of research at a South African laboratory, told Reuters on Tuesday.
Turkey donates 200,000 vaccine jabs to African countries
Turkey has donated 200,000 doses of COVID-19 vaccines to Burkina Faso and Togo, two Western African countries where the effects of the pandemic have had more troubling consequences than the rest of the world, in a campaign by the Organization of Turkic States.
Mixing Vaccines against COVID-19 provides better Protection
The immune response in people who received the first dose of COVID-19 vaccines from Astra Zeneca and Biontech / Pfizer with Moderna was higher, according to a large British study.
Second-dose jab rate increasing slowly, minister says
Initial data suggest that locally developed vaccine Turkovac is very effective against COVID-19, an expert has said, while Health Minister Fahrettin Koca has voiced concern over the slow pace in the jab drive, particularly in the second shot of the vaccine.
'Encouraging' early feedback on Omicron case severity: Fauci
Early indications of the severity of the Omicron COVID-19 variant are "a bit encouraging," top U.S. pandemic advisor Anthony Fauci said on Dec. 5, while cautioning more information was still needed.
Australia approves COVID vaccine for children aged 5-11
Australia on Dec. 5 cleared the first COVID-19 vaccine for children aged five to 11, with the next stage of its vaccine rollout expected to start in early 2022.
Health Minister Greg Hunt said medical regulators had granted provisional approval for the Pfizer-BioNTech vaccine to be administered to younger children for the first time.
Minister renews calls for getting jabbed, following rules
Health Minister Fahrettin Koca has once again called on the public to continue to adhere to the anti-virus rules and getting the vaccine against COVID-19.
BioNTech CEO: I think we will Need an Adapted Vaccine against COVID-19 because of Omicron
German biotech company BioNTech should be able to adapt its coronavirus vaccine relatively quickly in response to the Omicron variant, said its CEO Ugur Shahin, adding that despite the mutations, the vaccines must continue to protect people against serious illness.
EU Health Regulator is Launching a Review of a New Vaccine against COVID-19
The European Medicines Agency said today it had begun reviewing a new vaccine against COVID-19, produced by the French company Valneva - the first step towards approving its use in the European Union, the Associated Press reported.
Pfizer CEO: Vaccines against COVID-19 will Probably become Annual
COVID vaccination will probably be needed each year. This was stated by the CEO of Pfizer. Scientists believe they have found a link between the appearance of blood clots and the Astra Zeneca vaccine.